Literature DB >> 22627140

Pyruvate kinase M2 promotes the growth of gastric cancer cells via regulation of Bcl-xL expression at transcriptional level.

Oh-Hyung Kwon1, Tae-Wook Kang, Jeong-Hwan Kim, Mirang Kim, Seung-Moo Noh, Kyu-Sang Song, Hyang-Sook Yoo, Woo-Ho Kim, Zhi Xie, David Pocalyko, Seon-Young Kim, Yong Sung Kim.   

Abstract

PKM2 is an isoenzyme of the glycolytic enzyme pyruvate kinase that promotes aerobic glycolysis. Here, we describe an important role for PKM2 in regulating the survival of gastric cancer (GC) cells. We showed that PKM2 was overexpressed in gastric tumor tissues compared to normal tissues and its expression level was associated with poor survival of gastric cancer patients. We also showed that PKM2 affected cell survival by regulating Bcl-xL at the transcriptional level. PKM2 knockdown partially affected the stability of NF-kB subunit p65, suggesting that post-translational regulation of p65 by PKM2 is one of plausible mechanisms for the increased cell growth. Therefore, PKM2 may function as an upstream molecule that regulates p65 function and thus enhances the growth of tumor cells.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22627140     DOI: 10.1016/j.bbrc.2012.05.063

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  33 in total

Review 1.  The prognostic value of pSTAT3 in gastric cancer: a meta-analysis.

Authors:  S Yu; G Li; Z Wang; Z Wang; C Chen; S Cai; Y He
Journal:  J Cancer Res Clin Oncol       Date:  2015-08-02       Impact factor: 4.553

Review 2.  Dysregulated glycolysis as an oncogenic event.

Authors:  Takumi Mikawa; Matilde E LLeonart; Akifumi Takaori-Kondo; Nobuya Inagaki; Masayuki Yokode; Hiroshi Kondoh
Journal:  Cell Mol Life Sci       Date:  2015-01-22       Impact factor: 9.261

3.  Pyruvate kinase M2 and its evolving role as a prognostic marker in systemic malignancies besides colorectal carcinomas.

Authors:  Shailendra Kapoor
Journal:  Tumour Biol       Date:  2012-10-04

Review 4.  Glucose metabolism in gastric cancer: The cutting-edge.

Authors:  Lian-Wen Yuan; Hiroharu Yamashita; Yasuyuki Seto
Journal:  World J Gastroenterol       Date:  2016-02-14       Impact factor: 5.742

5.  Pantoprazole inhibits human gastric adenocarcinoma SGC-7901 cells by downregulating the expression of pyruvate kinase M2.

Authors:  Yonghua Shen; Min Chen; Shuling Huang; Xiaoping Zou
Journal:  Oncol Lett       Date:  2015-11-13       Impact factor: 2.967

Review 6.  Drugging cancer metabolism: Expectations vs. reality.

Authors:  David C Montrose; Lorenzo Galluzzi
Journal:  Int Rev Cell Mol Biol       Date:  2019-07-29       Impact factor: 6.813

7.  Regulatory circuit of PKM2/NF-κB/miR-148a/152-modulated tumor angiogenesis and cancer progression.

Authors:  Q Xu; L-Z Liu; Y Yin; J He; Q Li; X Qian; Y You; Z Lu; S C Peiper; Y Shu; B-H Jiang
Journal:  Oncogene       Date:  2015-02-23       Impact factor: 9.867

Review 8.  The Role of PKM2 in Metabolic Reprogramming: Insights into the Regulatory Roles of Non-Coding RNAs.

Authors:  Dexter L Puckett; Mohammed Alquraishi; Winyoo Chowanadisai; Ahmed Bettaieb
Journal:  Int J Mol Sci       Date:  2021-01-25       Impact factor: 5.923

9.  Pyruvate kinase M2 regulates apoptosis of intestinal epithelial cells in Crohn's disease.

Authors:  Qiyun Tang; Qianqian Ji; Weiwei Xia; Liren Li; Jian'an Bai; Runzhou Ni; Yongwei Qin
Journal:  Dig Dis Sci       Date:  2014-05-11       Impact factor: 3.199

10.  miR-122 inhibits cancer cell malignancy by targeting PKM2 in gallbladder carcinoma.

Authors:  Wei Lu; Yijian Zhang; Linzhu Zhou; Xuan Wang; Jiasheng Mu; Lin Jiang; Yunping Hu; Ping Dong; Yingbin Liu
Journal:  Tumour Biol       Date:  2015-11-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.